NCT00328172 · Interventional trial
Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients
Overall registry status Completed
Phase 2
Conditions Diabetes Mellitus, Type 2
Delaware Valley sites
- 1218.5.10030 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory